GB201820172D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB201820172D0 GB201820172D0 GBGB1820172.3A GB201820172A GB201820172D0 GB 201820172 D0 GB201820172 D0 GB 201820172D0 GB 201820172 A GB201820172 A GB 201820172A GB 201820172 D0 GB201820172 D0 GB 201820172D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1820172.3A GB201820172D0 (en) | 2018-12-11 | 2018-12-11 | Therapeutic agents |
| PCT/EP2019/050594 WO2019138017A1 (en) | 2018-01-15 | 2019-01-10 | Fused imidazole derivatives as il-17 modulators |
| ES19700777T ES2963417T3 (en) | 2018-01-15 | 2019-01-10 | Condensed Imidazole Derivatives as IL-17 Modulators |
| US16/959,339 US11472794B2 (en) | 2018-01-15 | 2019-01-10 | Fused imidazole derivatives as IL-17 modulators |
| EP19700777.6A EP3740478B1 (en) | 2018-01-15 | 2019-01-10 | Fused imidazole derivatives as il-17 modulators |
| CA3088764A CA3088764A1 (en) | 2018-01-15 | 2019-01-10 | Fused imidazole derivatives as il-17 modulators |
| CN201980008614.5A CN111601799B (en) | 2018-01-15 | 2019-01-10 | Fused imidazole derivatives as modulators of Il-17 |
| MA051610A MA51610A (en) | 2018-01-15 | 2019-01-10 | MERGED IMIDAZOLE DERIVATIVES USED AS IL-17 INHIBITORS |
| JP2020538917A JP7271557B2 (en) | 2018-01-15 | 2019-01-10 | Fused Imidazole Derivatives as IL-17 Modulators |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1820172.3A GB201820172D0 (en) | 2018-12-11 | 2018-12-11 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201820172D0 true GB201820172D0 (en) | 2019-01-23 |
Family
ID=65030238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1820172.3A Ceased GB201820172D0 (en) | 2018-01-15 | 2018-12-11 | Therapeutic agents |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201820172D0 (en) |
-
2018
- 2018-12-11 GB GBGB1820172.3A patent/GB201820172D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201820166D0 (en) | Therapeutic agents | |
| GB201820165D0 (en) | Therapeutic agents | |
| GB201909190D0 (en) | Therapeutic agents | |
| SG11202104461XA (en) | Therapeutic methods | |
| GB201909191D0 (en) | Therapeutic agents | |
| GB201909194D0 (en) | Therapeutic agents | |
| GB201709456D0 (en) | Therapeutic agents | |
| IL277336A (en) | Combination therapy | |
| GB201804255D0 (en) | Macrophage-based therapy | |
| GB201902277D0 (en) | Therapeutic agents | |
| GB201805816D0 (en) | Therapeutic agents | |
| GB201819853D0 (en) | Therapy | |
| IL280729A (en) | Combination therapy | |
| IL279908A (en) | Combination therapy | |
| GB201700553D0 (en) | Therapeutic agents | |
| GB201906804D0 (en) | Therapeutic agents | |
| SG11202101518QA (en) | Combination therapy | |
| GB201817385D0 (en) | Therapy | |
| GB201820170D0 (en) | Therapeutic agents | |
| GB201820168D0 (en) | Therapeutic agents | |
| GB201820162D0 (en) | Therapeutic agents | |
| GB201820160D0 (en) | Therapeutic agents | |
| GB201820164D0 (en) | Therapeutic agents | |
| GB201820172D0 (en) | Therapeutic agents | |
| GB201811753D0 (en) | Therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |